Exclusive

Publication

Byline

Location

US Patent Issued to INSTITUTE OF SCIENCE TOKYO on Oct. 27 for "Agent for preventing or treating frontotemporal lobar degeneration" (Japanese Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,326, issued on Oct. 27, was assigned to INSTITUTE OF SCIENCE TOKYO (Tokyo). "Agent for preventing or treating frontotemporal lobar degenera... Read More


US Patent Issued to Chugai Seiyaku on Oct. 27 for "Methods of treatment comprising administering an antibody that promotes disappearance of antigens having plurality of biological activities" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,327, issued on Oct. 27, was assigned to Chugai Seiyaku K.K. (Tokyo). "Methods of treatment comprising administering an antibody that promot... Read More


US Patent Issued to NantBio on Oct. 27 for "Methods of reducing epithelial-mesenchymal transition with an interleukin-8 antibody" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,328, issued on Oct. 27, was assigned to NantBio Inc. (Culver City, Calif.). "Methods of reducing epithelial-mesenchymal transition with an ... Read More


US Patent Issued to Reverb Therapeutics on Oct. 27 for "Cytokine-based therapies and methods" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,329, issued on Oct. 27, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada). "Cytokine-based therapies and methods" was invented b... Read More


US Patent Issued to Amgen on Oct. 27 for "Continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes" (California, Washington, Rhode Island, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,330, issued on Oct. 27, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Continuous manufacturing process for biologics manufacturing b... Read More


US Patent Issued to KYOWA KIRIN on Oct. 27 for "Bispecific antibody binding to CD3" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,331, issued on Oct. 27, was assigned to KYOWA KIRIN Co. LTD. (Tokyo). "Bispecific antibody binding to CD3" was invented by Rinpei Niwa (Tok... Read More


US Patent Issued to Genentech on Oct. 27 for "Anti-CD8 antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,332, issued on Oct. 27, was assigned to Genentech Inc. (South San Francisco, Calif.). "Anti-CD8 antibodies and uses thereof" was invented b... Read More


US Patent Issued to The Regents of the University of California on Oct. 27 for "Compositions and methods for making and using multispecific antibodies" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,333, issued on Oct. 27, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions and methods for making... Read More


US Patent Issued to Boehringer Ingelheim International on Oct. 27 for "B7H6 x CD3 binding proteins for cancer treatment" (American, Austrian, German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,334, issued on Oct. 27, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany). "B7H6 x CD3 binding proteins... Read More


US Patent Issued to Nexoplex Bio on Oct. 27 for "Antigen-binding proteins and related methods of use" (California, Massachusetts, Maryland Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,335, issued on Oct. 27, was assigned to Nexoplex Bio LLC (Jackson, Wyo.). "Antigen-binding proteins and related methods of use" was invente... Read More